Edwards Lifesciences Corp Long Term Debt

Quick Answer

Edwards Lifesciences Corp reported Long Term Debt of $598.30 million for the year ending 2025.

  • Edwards Lifesciences Corp showed an increase of +0.1% in Long Term Debt from 2024 to 2025.
  • This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q4 2009: $90.30 million | Q2 2010: $177.50 million | Q1 2014: $725.40 million | Q2 2014: $598.00 million | Q3 2014: $596.40 million | Q1 2015: $602.70 million | Q2 2015: $600.30 million | Q3 2015: $604.90 million | Q1 2016: $602.20 million | Q2 2016: $602.50 million | Q3 2016: $600.60 million | Q1 2017: $847.90 million | Q2 2017: $1.02 billion | Q3 2017: $1.03 billion | Q1 2018: $456.00 million | Q2 2018: $593.90 million | Q3 2018: $593.60 million | Q1 2019: $593.90 million | Q2 2019: $594.10 million | Q3 2019: $594.20 million | Q1 2020: $594.60 million | Q2 2020: $594.70 million | Q3 2020: $594.90 million | Q1 2021: $595.20 million | Q2 2021: $595.40 million | Q3 2021: $595.50 million | Q1 2022: $595.90 million | Q2 2022: $596.00 million | Q3 2022: $596.20 million | Q1 2023: $596.50 million | Q2 2023: $596.70 million | Q3 2023: $596.80 million | Q1 2024: $597.20 million | Q2 2024: $597.30 million | Q3 2024: $597.50 million | Q1 2025: $597.80 million | Q2 2025: $598.00 million | Q3 2025: $598.20 million.
  • Over the full 14 years of available data (2012 to 2025), Edwards Lifesciences Corp's Long Term Debt has grown by 216.1%.
  • Historical annual values: Fiscal year 2025: $598.30 million | Fiscal year 2024: $597.70 million | Fiscal year 2023: $597.00 million | Fiscal year 2022: $596.30 million | Fiscal year 2021: $595.70 million | Fiscal year 2020: $595.00 million | Fiscal year 2019: $594.40 million | Fiscal year 2018: $593.80 million | Fiscal year 2017: $438.40 million | Fiscal year 2016: $822.30 million | Fiscal year 2015: $596.90 million | Fiscal year 2014: $598.10 million | Fiscal year 2013: $593.10 million | Fiscal year 2012: $189.30 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: